News & Events
February 22, 2023
Breaking Down Barriers in Support of Patients with Rare DiseasesYou’re invited to join C-Path’s Gina Calarco Smith at the upcoming Breaking Down Barriers in Support of Rare Diseases webinar. Smith, Scientific Director of Pediatrics at C-Path, will be on a panel of rare disease experts who will break down the latest in drug development, clinical trials, patient advocacy and more. Hosted by Labcorp on Wednesday, February......
November 15, 2022 - November 16, 2022
View Now | INC 2022 Scientific Meeting
We’re excited to see you at the International Neonatal Consortium 2022 Scientific Meeting this fall. #INC2022 will feature presentations by collaborators from industry, academia, regulatory agencies (FDA, EMA, and PMDA), patient organizations and more.
October 19, 2021 - October 20, 2021
VIEW NOW | 2021 INC Scientific Meeting
C-Path’s International Neonatal Consortium will host its two-day annual scientific meeting in a virtual format, October 19-20, 2021.
October 28, 2020 - October 29, 2020
View Now | October 28-29 | International Neonatal Consortium 2020 Virtual Workshop
This two-day virtual workshop, hosted in collaboration with EMA, will bring together hundreds of INC consortia members and collaborators from across the world, ranging from academic and industry researchers, regulators, parent and nursing representatives, to discuss some of the most important topics in the field of neonatology research, including:
Racial and health equity in neonatal clinical trials
Clinical trial design and execution
Treatments administered to pregnant women for the benefit of neonates
Using real-world-data to generate real-world-evidence in neonatology
Each topic will feature presentations by subject matter experts, followed by a panel discussion and Q&A session.
Register now: https://bit.ly/INC2020Workshop
May 1, 2019 - May 3, 2019
2019 Annual INC Neonatal Scientific WorkshopMay 1-3, 2019 Hyatt Regency Bethesda, Maryland Meeting Objectives: Share regulatory perspectives on developing safe and effective therapies for neonates. Provide foundational knowledge on innovative, regulated medicines development and factors influencing Go/No-Go decisions throughout the development pipeline. Discuss endpoints for clinical trials to evaluate pain medications. Address neonatal opioid issues through optimizing trial design for......